国际检验医学杂志
國際檢驗醫學雜誌
국제검험의학잡지
INTERNATIONAL JOURNAL OF LABORATORY MEDICINE
2015年
3期
331-332,335
,共3页
睾酮%雄激素%雄激素受体%三阴性乳腺癌
睪酮%雄激素%雄激素受體%三陰性乳腺癌
고동%웅격소%웅격소수체%삼음성유선암
testosterone%androgen%androgen receptor%triple negative breast cancer
目的:探讨三阴性乳腺癌与非三阴性乳腺癌患者间睾酮和雄激素受体(AR)水平的差异及临床意义。方法按照纳入标准选取该院经病理确证为原发性乳腺癌的患者,共92例女性患者,其中三阴性乳腺癌42例,非三阴性乳腺癌50例,统计分析三阴性与非三阴性乳腺组患者年龄、组织学分级、病理分期、血清睾酮水平和 AR 的差异。结果三阴性乳腺癌组和非三阴性乳腺癌组比较,三阴性乳腺癌组血清睾酮水平低于非三阴性乳腺癌组,差异有统计学意义(P <0.05);三阴性乳腺癌组 AR 阳性率为57%,非三阴性乳腺癌 AR 阳性率为82%,差异有统计学意义(P <0.05)。结论雄激素和 AR 可能成为三阴性乳腺癌新的治疗突破点。
目的:探討三陰性乳腺癌與非三陰性乳腺癌患者間睪酮和雄激素受體(AR)水平的差異及臨床意義。方法按照納入標準選取該院經病理確證為原髮性乳腺癌的患者,共92例女性患者,其中三陰性乳腺癌42例,非三陰性乳腺癌50例,統計分析三陰性與非三陰性乳腺組患者年齡、組織學分級、病理分期、血清睪酮水平和 AR 的差異。結果三陰性乳腺癌組和非三陰性乳腺癌組比較,三陰性乳腺癌組血清睪酮水平低于非三陰性乳腺癌組,差異有統計學意義(P <0.05);三陰性乳腺癌組 AR 暘性率為57%,非三陰性乳腺癌 AR 暘性率為82%,差異有統計學意義(P <0.05)。結論雄激素和 AR 可能成為三陰性乳腺癌新的治療突破點。
목적:탐토삼음성유선암여비삼음성유선암환자간고동화웅격소수체(AR)수평적차이급림상의의。방법안조납입표준선취해원경병리학증위원발성유선암적환자,공92례녀성환자,기중삼음성유선암42례,비삼음성유선암50례,통계분석삼음성여비삼음성유선조환자년령、조직학분급、병리분기、혈청고동수평화 AR 적차이。결과삼음성유선암조화비삼음성유선암조비교,삼음성유선암조혈청고동수평저우비삼음성유선암조,차이유통계학의의(P <0.05);삼음성유선암조 AR 양성솔위57%,비삼음성유선암 AR 양성솔위82%,차이유통계학의의(P <0.05)。결론웅격소화 AR 가능성위삼음성유선암신적치료돌파점。
Objective To investigate the difference of serum testosterone and androgen receptor(AR)concentrations between triple negative breast cancer patients and non-triple negative breast cancer patients and its clinical significance.differences and clini-cal significance.Methods According to the inclusion criteria,a total of 92 female patients were enrolled in the study including 42 patients with triple negative breast cancer and 50 patients with non-triple negative breast cancer.The patients recruited all seeked medical advice in hospital and diagnosed with primary breast cancer by using pathological method.Age,histological grade,patholog-ical stage,serum testosterone and AR concentrations were compared between triple negative breast and non-triple-negative group and statistically analyzed.Results Compared between triple negative breast and non-triple-negative group,the serum testosterone concentrations of triple negative breast was lower and the difference were statistically different(P <0.05);AR-positive rate of triple negative breast cancer group was 57%,AR-positive rate of non-triple-negative breast cancer was 82%,the difference was statistical-ly significant(P <0.05).Conclusion Androgen and AR may be a prognostic therapeutic target in triple negative breast cancer.